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The green fluorescent protein (GFP) of the jellyfish, Aeqorea victoria, was used as an autofluorescent tag to track the trafficking of aquaporin 5
(AQP5), an exocrine gland-type water channel. Two groups of chimeric proteins were constructed; one in which GFP was fused to the amino-
terminus of AQP5 (GFP–AQP5) and the other, in which it was fused to the carboxyl terminus of it (AQP5–GFP). In each group, 2 chimeras were
produced, a wild-type AQP5 with its normal sequence and a mutant AQP5 having a mutated amino acid at 259, i.e., GFP–AQP5–T259A and
AQP5–GFP–T259A. They were used to transfect Madin–Darby canine kidney (MDCK) cells. The GFP–AQP5 chimera was localized in the
intracellular vesicles, which trafficked to the plasma membrane in response to N6, 2′-O-dibutyryladenosine 3′, 5′-cyclic monophosphate
(dbcAMP). Membrane trafficking was inhibited by N-[2-(p-bromocinnamylamino)ethyl]-5-isoquimolinesulfonamide (H-89) but not by palmitoyl-
DL-carnitine chloride (PCC). In contrast, the AQP5–GFP chimera expressed in MDCK cells was localized constitutively on the plasma membrane.
The cellular localization of the latter chimera was not affected by stimulation with dbcAMP in the presence or absence of H-89 or PCC.
Replacement of Thr-259 with Ala-259 did not affect the dbcAMP-induced translocation of the chimeric protein, suggesting that phosphorylation
of Thr-259 was not necessary for AQP5 trafficking under the present experimental conditions. Thus, the GFP–AQP5 chimera will be a useful tool
to study AQP5 trafficking in vitro, whereas the constitutive membrane localization of the AQP5–GFP chimera suggests the importance of the
carboxyl terminus of the AQP5 protein for its sorting, whether it is translocated to intracellular vesicles or to the plasma membrane.
© 2006 Elsevier B.V. All rights reserved.Keywords: Aquaporin 5; Trafficking; GFP-tagged AQP5Abbreviations:AQP5, aquaporin 5; dbcAMP,N6, 2′-O-dibutyryladenosine 3′, 5′-cyclic monophosphate; DMEM/F-12, Dulbecco's modified Eagle's medium F-12
HAM; ECL, enhanced chemiluminescence; EDTA, ethylenediaminetetraacetic acid; FBS, fetal bovine serum; GFP, green fluorescent protein; GLUT, glucose
transporter; HRP, horseradish peroxidase; H-89, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfoamide; MDCK, Madin–Darby canine kidney; PBS,
phosphate-buffered saline; PCC, palmitoyl-DL-carnitine chloride; PKA, protein kinase A; PKC, protein kinase C; PKG, protein kinase G; PMA, phorbol 12-myristate
13-acetate; PMSF, phenyl methylsulfonyl fluoride; SDS-PAGE, sodium dodecylsulfate-polyacrylamide gel electrophoresis
☆ Nucleotide numbering: The first nucleotide, adenine at the translation initiation site (ATG) was denoted as nucleotide number one in this paper. Designation of
plasmid constructs: Plasmid constructs established in the present study are designated as follows: pEGFP-C2 vector ligated to rAQP5 cDNA, GFP–AQP5; pEGFP-N2
vector ligated to rAQP5 cDNA, AQP5–GFP; pEGFP-C2 vector ligated to rAQP5 cDNAwith mutation at nt 775, GFP–AQP5–T259A; pEGFP-N2 vector ligated to
rAQP5 cDNA with mutation at nt 775, AQP5–GFP–T259A.
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Underline, restriction enzyme recognition sequence; Double underline, muta-
tional sequence.
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Aquaporin (AQP) water channels are essential for mediating
rapid osmotic water transport across the cell membrane. There are
13 known mammalian AQPs. Among them, AQP5 was first
identified in the salivary gland and subsequently in other exocrine
glands; and it was found to be localized consistently at the apical
membranes of acinar cells in the submandibular and parotid
glands of rats [1–4]. The vesicular trafficking is one of
mechanisms that regulate AQP functions. AQP5 is translocated
from intracellular to the plasma membrane in response to the
elevation of intracellular Ca2+, where involvement of the
cytoskeleton is suggested [5,6]. In a murine lung epithelial cell
line (MLE-12), a cAMP analog, 8-(4-chlorophenylthio)-cAMP
(cpt-cAMP), was recently found to induce AQP5 expression both
transcriptionally and post-transcriptionally [7]. AQP2 is the water
channel, which has been studied more regarding the event after
second messenger-induced phosphorylation. It is reported that
activation of protein kinase A (PKA) by cAMP leads to
phosphorylation of AQP2 at Ser-256, the amino acid residue
located at the cytoplasmic domain of carboxyl terminus. By the
use of LLC-PK1 cells (a pig kidney line typical of normal kidney
tubular epithelium) transfected with S256A-mutant AQP2, it was
shown that phosphorylation of the Ser-256 residue by PKA is
required for vasopressin-induced translocation of AQP2 from
vesicles toward the plasma membrane [8,9]. van Balkom et al.
[10] constructed altered AQP2 genes, each of which produced a
product with a mutation at either putative casein kinase II-target
motifs (Ser-148, Ser-229, Thr-244), a protein kinase C (PKC)-
target motif (Ser-231), or a PKA-target motif (Ser-256); theywere
then expressed inMadin–Darby canine kidney (MDCK) cells. All
of these mutant proteins, except that of Ser-256 mutant trafficked
from intracellular vesicles to the apical membrane via a forskolin-
sensitive mechanism, similarly as wild-type AQP2 did [10].
The green fluorescent protein (GFP) has recently become
available for studying the behavior/localization of particular
proteins in the living system. The intracellular distribution of
exogenously expressed GFP-protein chimeras can be directly
tracked without the need for chemical fixation and antibody
staining. Such chimeric proteins can ultimately be used to
follow intracellular trafficking pathways in real time, but a
major caveat is that the GFP–AQP5 chimeras may not be
handled by the intracellular sorting machinery in the same way
as the native protein in cells of any given type. For example,
although both of the glucose transporter-4 (GLUT4) connected
to GFP at its amino-terminus and the same protein with GFP at
its carboxyl terminus are translocated to the plasma membrane
in response to insulin, only the GLUT4 tagged with GFP at its
carboxy terminus is re-internalized upon insulin removal [11].
The GLUT4 tagged with GFP at the amino terminus remains on
the plasma membrane [11]. In the study of AQP2 trafficking,
the GFP–AQP2 chimera (GFP fused to the amino-terminus of
AQP2) expressed in LLC-PK1 cells was found to traffick in a
regulated pathway from intracellular vesicles toward the
basolateral plasma membrane in response to vasopressin or
forskolin stimulation. In contrast, the AQP2–GFP chimera
(GFP fused to the carboxyl terminus of AQP2) was localizedconstitutively on both apical and basolateral plasma mem-
branes. The cellular localization of this chimera was not
modified by vasopressin or forskolin [12].
The present study was aimed at assessing the cellular
regulation of AQP5 trafficking. For this purpose, we
constructed two types of chimeras, one in which GFP was
fused to the amino-terminus of AQP5, designated as GFP–
AQP5, and the second in which GFP was fused to the
carboxy-terminus of AQP5, designated as AQP5–GFP.
MDCK cells were transfected with these chimeras for analysis
of their trafficking pathways. Furthermore, to determine the
role of the putative phosphorylation site at the C-terminal
domain in the regulation of AQP5 trafficking, a PKA/protein
kinase G (PKG) target site (Thr-259) was altered to Ala so that
this residue would not be phosphorylated when the mutated
protein was expressed in MDCK cells.
2. Materials and methods
2.1. Reagents
ISOGENwas purchased fromNipponGene (Tokyo, Japan). RNaseHMinus,
M-MLV reverse transcriptase and pGEM-T Easy vector were from Promega
(Madison, WI). QIA quick Gel Extraction kit was from Qiagen (Tokyo, Japan).
Two types of vectors, pEGFP-C2 and pEGFP-N2, and anti-GFP antibody (BD
Living Colors™, A.v. Peptide Antibody) were obtained from BD Biosciences
Clontech (Palo Alto, CA). Dulbecco's modified Eagle's medium F-12 HAM
(DMEM/F-12), N6, 2′-O-dibutyryladenosine 3′, 5′-cyclic monophosphate
(dbcAMP), palmitoyl-DL-carnitine (PCC), G418, and phorbol 12-myristate 13-
acetate (PMA) were procured from Sigma-Aldrich (Tokyo, Japan).
Lipofectamine 2000 Reagent was from Invitrogen (Tokyo, Japan); and N-
[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfoamide (H-89), from Sei-
kagaku Corporation (Tokyo, Japan). Horseradish peroxidase (HRP)-conjugated
donkey anti-rabbit IgG and enhanced chemiluminescence (ECL) Western
Blotting Detection System were procured from Amersham Biosciences
(Piscataway, NJ). Alexa Fluor™ 594-conjugated goat anti-rabbit IgG (H+L)
antibody was from Molecular Probes (Eugene, OR). Glass-bottomed microwell
dishes came from MatTek Corporation (Ashland, MA).
2.2. PCR-cloning of AQP5 cDNA and construction of GFP-fusion
genes
Total RNA was prepared from rat submandibular glands by using
ISOGEN and treated with DNaseI at 37 °C for 1 h. cDNA was synthesized
from 2 μg of total RNA with random hexamers and M-MLV reverse
transcriptase, RNase H Minus, at 37 °C for 1 h. The cDNA of rat AQP5
Fig. 1. Immunoblot analysis of the fusion proteins of GFP and AQP5
expressed in MDCK stable transfectants. Aliquots of 10 μg protein of the total
membrane fraction from normal and transfected MDCK cells were separated
by SDS-PAGE (10% polyacrylamide gel) and probed with the antibodies
indicated below. (A) Blots probed with anti-AQP5 antibody (lanes 1–3) and
with anti-AQP5 antibody pre-absorbed with antigen peptide (p-Ab; lane 4).
Lane 1, control cells (cells without transfection); lane 2, cells transfected with
pEGFP-C2 vector; lanes 3 and 4, cells transfected with GFP–AQP5. (B) Blots
probed with anti GFP antibody. Lane 1, control cells (cells without
transfection); lane 2, cells transfected with pEGFP-N2 vector; lane 3, cells
transfected with AQP5–GFP. The molecular weight of standard markers in
kDa is indicated on the left.
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upstream of the translation initiation codon (ATG), was then amplified by
PCR using the primer pairs listed in Table 1. Namely, for construction of
GFP–AQP5, 2 primer sets were designed, i.e., rAQP5K-6 (sense) and
rAQP5K-8 (antisense) for the wild-type construct, and rAQP5K-6 (sense)
and rAQP5K-12 (antisense) for the T259A mutant construct. The PCR
products produced by using these primers were sub-cloned in the pGEM-T
Easy vector, and then ligated to pEGFP-C2 as described below. Similarly,
the primer set rAQP5K-5 (sense) and rAQP5K-4 (antisense) was designed
for construction of wild-type AQP5–GFP; and the set rAQP5K-5 (sense) and
rAQP5K-11 (antisense), for the T259A mutant-type AQP5–GFP. The PCR
products produced by using these primers were sub-cloned, and ligated
to pEGFP-N2 (see below). The PCR conditions were set as follows:
denaturation at 96 °C for 30 s, annealing at 61 °C for 30 s, and extension
at 72 °C for 80 s. These steps were repeated for 35 cycles following
an initial denaturation at 96 °C for 10 min. The resulting PCR product
was cloned in the pGEM-T Easy vector according to the manufacturer's
protocol.
To prepare the GFP–AQP5 or the AQP5–GFP fusion chimeras, we double
digested the pGEM-T Easy vector containing the AQP5 cDNAwith XhoI/EcoRI
sites at its 5′ and 3′ ends with XhoI and EcoRI restriction enzymes to excise the
insert from the vector. The insert DNA (AQP5 cDNA) was separated from the
vector DNA by agarose gel electrophoresis and purified by using the QIA quick
Gel Extraction kit. The DNAwas ligated to vector pEGFP-C2 or vector pEGFP-
N2 at the XhoI/EcoRI sites, as indicated above.
2.3. Cell culture and stable transfection
MDCK cells were cultured in DMEM/F-12 containing 5% fetal bovine
serum (FBS), 100 U/ml of penicillin, and 100 μg/ml of streptomycin. The
cells were cultured at 37 °C under a humidified 5% CO2 atmosphere. By use
of the Lipofectamine 2000 Reagent, 10 μg each of wild-type and T259A-
mutant of the GFP–AQP5 and AQP5–GFP expression constructs, and the
GFP vector without an insert, were used to transfect MDCK cells that had
been grown on 9 cm-dishes to a subconfluent density. After 48 h of
incubation, the transfected cells were selected upon cultivation for 2 weeks
in medium containing 1 mg/ml of G418. The resultant clones were isolated,
expanded to large cultures, and subjected to further analysis.
2.4. Antibodies
AQP5 antibody used in the present study was raised by injecting a rabbit
with a mixture of Freund's complete adjuvant containing M. Butyricum
and the carboxyl-terminal peptide of rat AQP5 (NH2-CDHREERKKTIELL-
TAH-COOH) conjugated to keyhole limpet hemocyanin. The specificity of
this antibody was confirmed by Western blotting conducted as reported
previously [13].
2.5. Western blotting
Transfected MDCK cells grown on 9-cm plastic dishes were treated with
900 μl of lysis buffer (10 mM Tris–HCl, pH 8.0, containing 1% Triton-X-100,
50 mM NaCl, 5 mM ethylenediaminetetraacetic acid (EDTA), 1 mM phenyl
methylsulfonyl fluoride (PMSF), and 1 μg/ml aprotinin) at 4 °C for 5 min. The
resulting cell lysates were homogenized by the use of a glass/Teflon
homogenizer, and centrifuged at 800×g for 10 min at 4 °C to remove the
nucleus and cell debris. The supernatant obtained was centrifuged at
105,000×g for 1 h at 4 °C, after which the pellet was collected and re-
suspended in the homogenization buffer. A small portion of the supernatant
was used for protein measurement. Ten micrograms of the total membrane
protein was separated by 10% sodium dodecylsulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and transferred to a nitrocellulose filter. After
having been blocked with phosphate buffered saline (PBS) containing 1% or
5% skim milk (for anti-AQP5 and anti-GFP antibodies, respectively), the filter
was incubated at 4 °C overnight with either anti-AQP5 antiserum diluted at
1:3000 or anti-GFP antibody diluted at 1:200. To verify the specificity of
positive bands, we performed a control experiment with the same concentrationof antibody that had been treated with 40 μg/ml of the immunizing peptide.
The filter was then washed and incubated with HRP-conjugated goat anti-
rabbit IgG diluted at 1:3000 for 1 h at room temperature. The filter was finally
subjected to an ECL Western Blotting Detection System and exposed to Fuji
RX X-ray film.
2.6. Fluorescence microscopy
For observation of GFP fluorescence, non-fixed cells cultured at a density
of near-confluence on glass-bottomed microwell dishes were imaged by
means of a fluorescence microscope (Model IX71, Olympus, Japan). For
staining of AQP5 by Alexa Fluor™ 594, the cells fixed with paraformal-
dehyde were treated with 0.1% Triton X-100 in PBS for 15 min at room
temperature to expose intracellular antigenic sites. The cells were then washed
3 times with PBS, blocked with 0.2% gelatin in PBS for 1 h, and incubated
with 500-times diluted rabbit anti-AQP5 antiserum for 1 h at room
temperature. The cells were next washed with the blocking solution and
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IgG (H+L) for 1 h at room temperature. GFP and Alexa Fluor™ 594
fluorescence were observed by using U-MNIBA2 and U-MWIG2 filters
(Olympus, Tokyo Japan), respectively.
2.7. Treatments with dbcAMP and H-89 or PCC
Approximately 72 h before dbcAMP treatment, cells were plated on
glass-bottomed microwell dishes and cultured for 48 h in the medium
described above. The medium was then replaced with DMEM/F12
containing 0.5% fetal bovine serum. After 24 h of serum-starvation,
different concentrations of dbcAMP were added to separate cultures, which
were then incubated for 18 h. Thirty micromolar H-89 or 10 μM PCC was
added to the cultures 6 h before the addition of dbcAMP to inhibit PKA or
PKC, respectively.
3. Results
3.1. Expression of GFP–AQP5 and AQP5–GFP chimeric
proteins
Two GFP vectors were used to construct two AQP5
chimeric proteins. Normal AQP5 cDNA was fused to the 3′-
or 5′-end of the GFP gene in pEGFP-C2 or pEGFP-N2
vectors, and the resulting protein products expressed in
transfected cells were designated as GFP–AQP5 and
AQP5–GFP, respectively. MDCK cells ware stably transfected
with either GFP–AQP5 or AQP5–GFP or with their mutant
constructs. Expression of the full-length fusion proteins in
stably transfected MDCK cells was confirmed by Western
blotting using anti-AQP5 antibody and anti-GFP polyclonal
antibody.
In the MDCK cells transfected with GFP–AQP5, the anti-
AQP5 antibody detected a 54-kDa band which concurredFig. 2. Cellular localization of fusion proteins of GFP and AQP5 inMDCK stable trans
with GFP–AQP5; (D) cells transfected with pEGFP-N2 vector, (E), cells transfected
fluorescence of Alexa Fluor™ 594 from the conjugate with goat anti-rabbit IgG, us
antibody). This micrograph exhibits fluorescence with a location identical to that ofwith the expected size for the chimeric protein (27 kDa
GFP+27-kDa AQP5; Fig. 1A, lane 3). When the antibody
was preabsorbed with AQP5 C-terminal peptide, this band
was completely absent thus indicating that the antiserum
detected specifically the chimeric protein (Fig. 1A, lane 4).
Similarly, the chimeric protein of 54 kDa was detected with
anti-GFP polyclonal antibody in the AQP5–GFP transfected
cells (Fig. 1B, lane 3). The anti-AQP5 antibody did not
detect AQP–GFP (data not shown) since this antibody was
reactive only to C-terminal sequence of AQP5 (see Materials
and methods and [13]), and since GFP was connected to this
domain in the chimeric protein. The pEGFP-N2-vector
transfected cells exhibited a 27-kDa GFP band with anti-
GFP antibody (Fig. 1B, lane 2), and no bands were detected
in control cells without transfection (Fig. 1A and B, lane 1).
These results suggest that the GFP vector and GFP–AQP5 or
AQP5–GFP chimeras were successfully expressed in MDCK
cells.
3.2. Localization of GFP–AQP5 and AQP5–GFP chimeric
proteins in MDCK cells
The fusion proteins of GFP and AQP5 expressed in MDCK
cells were detected by using a fluorescent microscopy. The
GFP–AQP5 protein was localized primarily on intracellular
vesicles, as seen by the inherent fluorescence of GFP (Fig.
2B). By staining with the anti-AQP5 antibody and Alexa
Fluor™ 594-conjugated goat anti-rabbit IgG (H+L) antibody
(Fig. 2C), the AQP5 label was shown to overlap completely
the GFP fluorescence, indicating that the localization as
revealed by the inherent GFP fluorescence was due to the
GFP–AQP5 fusion protein, not to GFP protein that might befectants. (A) Cells transfected with pEGFP-C2 vector, (B and C) cells transfected
with AQP5–GFP. (A, B, D, and E) Inherent green fluorescence of GFP. (C) Red
ed as a secondary antibody to localize the primary antibody (rabbit anti-AQP5
the inherent fluorescence by GFP shown in (B). Scale bars: 30 μm.
Fig. 3. Effects of dbcAMP, H-89, and PCC on cellular localization of GFP–
AQP5 and AQP5–GFP in MDCK stable transfectants. (A–F) MDCK cells
transfected with GFP–AQP5; (G and H) MDCK cells transfected with AQP5–
GFP. Cells were incubated in the absence (A, B, G, and H) or presence of 30 μM
H-89 (C and D) or 20 μM PCC (E and F) for 24 h. B, D, F, and H, 500 μM
dbcAMP was added to cell cultures identical to those of A, C, E, and G 6 h after
addition of inhibitors, and the cells were cultured for a further 18 h. Scale bars:
30 μm.
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hand, MDCK cells transfected with the pEGFP-C2 vector
exhibited localization of GFP fluorescence mainly on the
cytoplasmic area (Fig. 2A). Therefore, the inherent fluores-
cence of the GFP–AQP5 chimera was suitable and appropriate
for monitoring the trafficking of AQP5 in this cell culture
system.
In contrast to the AQP5 fusion protein with GFP at its amino-
terminus, the carboxyl terminus fusion protein was predomi-
nantly localized on plasma membranes under non-stimulated
condition, with only a small amount detected on the intracellular
structures (Fig. 2E). MDCK cells transfected with the pEGFP-
N2 vector exhibited localization of GFP fluorescence mainly on
the cytoplasmic area (Fig. 2D). Therefore, AQP5 fusion
proteins with GFP at its carboxy terminus and amino terminus
were concluded to be localized in completely different places;
i.e., on the plasma membrane and on intracellular vesicles,
respectively (Fig. 2B and E). Thus, the presence of the GFP
protein at the carboxyl terminus of AQP5 appears to have
caused spontaneous movement of this molecule toward the
plasma membrane.
3.3. Effects of dbcAMP on the trafficking of GFP–AQP5
protein in MDCK cells
To determine whether the GFP–AQP5 chimera retains its
capacity to traffick in response to second messengers, we
treated MDCK cells expressing GFP–AQP5 protein with 100,
300, 500, 700 or 1000 μM dbcAMP for different time. We
initially examined the membrane trafficking of GFP–AQP5
for 20 min with 15-s interval and 4 h with 30-min interval. No
translocation of the present molecules took place during this
time span. The time course study taking longer time was then
conducted and translocation was observed around 18 h after
which the membrane localization was stable until 24 h. The
dose response experiment was also carried out. Compared
with the control cells receiving no additive (Fig. 3A), cells
treated with 500–1000 μM dbcAMP showed the apparent
translocation of GFP–AQP5 from cytoplasmic vesicles to the
plasma membrane, and therefore the result with 500 μM
dbcAMP is shown in Fig. 3B. Obscure and modest
translocation of the chimeric protein was observed at 100–
300 μM dbcAMP. To determine whether PKA activity was
required for the effects of dbcAMP on GFP–AQP5 translo-
cation, we tested the effect of H-89, a PKA inhibitor; i.e., H-
89 (30 μM) was added at 6 h before the addition of 500 μM
dbcAMP. Immunofluorescent micrographs of cells treated with
dbcAMP in the presence of H-89 showed a strong
fluorescence at the cytoplasmic vesicles (Fig. 3D) as compared
with cells treated with dbcAMP alone (Fig. 3B), thus
suggesting the involvement of PKA in this trafficking. The
addition of H-89 alone did not cause any change in the cellular
localization of GFP–AQP5 (Fig. 3C). By using a motif search
program (GENETYX-MAC), we found a putative PKC target
motif at amino acid residues 152–154 (Ser–Arg–Arg) which
partially overlaps the PKA/PKG target motif (amino acid
residue 153–156; Arg–Arg–Thr–Ser). We therefore examinedif activation of PKC would affect the translocation of AQP5.
The incubation of the transfected cells with 100 nM PMA,
however, did not cause trafficking of AQP5 (data not shown).
We also examined the effects of PCC, a PKC inhibitor, to
determine whether the inhibition of this kinase would affect
GFP–AQP5 translocation by dbcAMP. dbcAMP in the
presence of PCC (Fig. 3F) showed a similar effect as that
seen in the absence of PCC (Fig. 3B). PCC alone did not have
any effect on the translocation of GFP–AQP5 (Fig. 3E).
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cultured under the normal condition (with no added
stimulants/inhibitors) expressed the chimeric protein at cell
membrane (Fig. 3G), which localization was not affected by
dbcAMP (Fig. 3H).
3.4. Effects of T259A on the trafficking of AQP5 protein in
MDCK cells
The sequence of the PKA target motif in a C-terminal
intracellular domain of AQP2 (253–256) is believed to be
important for AQP2 to translocate to the plasma membrane via a
mechanism in which cAMP is involved [8]. AQP5 has a
consensus PKA/PKG-target motif (Arg–Lys–Lys–Thr) in a
cytoplasmic loop located similarly as that of AQP2. ToFig. 4. Western blot analysis and cellular localization of T259Amutant of GFP–AQP5
blotting of wild-type and mutant AQP5 chimeric proteins. Aliquots of 10 μg ce
polyacrylamide gel) and probed with various antibodies. Lanes 1–3, blots probed with
with antigen peptide (p-Ab; lane 3). Lane 1, cells transfected with wild-type GFP–AQ
and 5, blots probed with anti GFP antibody. Lane 4, cells transfected with wild-type A
Fluorescence microscopy of MDCK cells transfected with GFP–AQP5–T259A (B–
additives; (C and F) incubation in the presence of 500 μM dbcAMP for 24 h. (D) Inc
respectively). Scale bars: 30 μm.determine whether the putative PKA/PKG target motif
participated in translocation of AQP5 to the plasma membrane,
we mutated Thr-259 in this site to Ala to retain the non-
phosphorylated state. MDCK cells were stably transfected with
GFP–AQP5–T259A and AQP5–GFP–T259A expression con-
structs of these mutant proteins. In immunoblot analysis of
selected clones, these transfectants expressed 54-kDa mutant
proteins, the size of which was exactly the same as that for
GFP–AQP5 (Fig. 4A). Fluorescence microscopy of the clones
expressing fusion proteins for mutant AQP5 with GFP at the
amino- or carboxy-terminus showed localization similar to that
of the respective wild-type AQP5 (Fig. 4B and E). Stimulation
of the cells with the dbcAMP caused translocation of GFP–
AQP5–T259A to the plasma membrane, in similar way as
demonstrated for GFP–AQP5 (Fig. 4C). H-89 inhibited theand AQP5–GFP fusion protein in MDCK cells stable transfectants. (A)Western
ll lysates from transfected MDCK cells were separated by SDS-PAGE (10%
anti-AQP5 antibody (lanes 1 and 2) and with anti-AQP5 antibody pre-absorbed
P5; lanes 2 and 3, cells transfected with a mutant, GFP–AQP5–T259A. Lanes 4
QP5–GFP; lane 5, cells transfected with the mutant AQP5–GFP–T259A. (B–F)
D) and AQP5–GFP–T259A (E and F). (B and E) Incubation in the absence of
ubated in the presence of 500 μM dbcAMP and 30 μM H-89 (for 24 h and 18 h,
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AQP5–GFP–T259A was localized in the plasma membrane
(Fig. 4E), and dbcAMP did not induce any change in its cellular
localization (Fig. 4F).
4. Discussion
In this report, we described the production and initial
characterization of two MDCK cell lines, one expressing
GFP–AQP5 and the other AQP5–GFP. Our study was
conducted to examine the effect of the GFP fusion site of
the AQP5 molecule on its intracellular translocation or
trafficking. The amino-terminal fusion chimera, GFP–AQP5,
was shown to exist at intracellular vesicles under the
unstimulated condition and to translocate from these vesicles
to the plasma membrane upon stimulation with dbcAMP (Fig.
3A and B). In contrast to GFP–AQP5, the AQP5–GFP fusion
protein was localized consistently at the plasma membrane
(Fig. 3G and H). Gustafson et al. [12] constructed the amino-
terminal and/or carboxy-terminal fusion chimeras of another
water channel, AQP2 (GFP–AQP2, and AQP2–GFP, respec-
tively), and transfected LLC-PK1 cells with them. They
reported that the GFP–AQP2 fusion protein was localized on
intracellular vesicles whereas the other one, AQP2–GFP,
constitutively localized at the apical and basolateral mem-
brane under the unstimulated condition. Their GFP–AQP2
fusion protein was translocated to the plasma membrane upon
stimulation of the cells with vasopressin or forskolin.
Therefore, the behavior of the present two fusion proteins,
AQP5–GFP and GFP–AQP5, is very similar to that of those
two AQP2 fusion proteins, supporting the hypothesis that an
important targeting motif(s) exist on the carboxy-terminus of
AQP5 as well as that of AQP2. In fact, Noda et al. [14]
recently reported that PDZ domain of the protein product,
signal-induced proliferation-associated gene-1, which is a
GAP for Rap1, binds to AQP2 at its carboxy-terminus.
Existence of similar mechanism for AQP5 trafficking needs to
be determined.
The consensus sequence of the PKA target motif is located
in cytoplasmic loop D of AQP5 at amino acid residues 153–
156 (Arg–Arg–Thr–Ser, [15]). Based on the results obtained
from a motif search program, we found a putative PKC target
motif at amino acid residues 152–154 (Ser–Arg–Arg), which
overlaps with the PKA target consensus sequence. Further, we
found a putative PKA/PKG phosphorylation site at amino acid
residues 256–259 (Arg–Lys–Lys–Thr) in the carboxyl
terminus cytoplasmic region. Yang et al. [7] examined the
effects of cAMP on expression and translocation of AQP5 in
MLE-12 cells; they showed that cAMP regulates AQP5 at
multiple levels, by increasing synthesis of AQP5 mRNA and
by triggering translocation of AQP5 to the plasma membrane.
However, there are not many reports concerning the function
of these motifs in the trafficking of AQP5. In this study, we
showed that cells treated with 500 μM dbcAMP exhibited
trafficking of some vesicles bearing GFP–AQP5 protein
toward the plasma membrane although many of these vesicles
still remained in the cytoplasm. Furthermore, we examined ifPKA, PKC or PKG is involved in dbcAMP-induced
trafficking of GFP–AQP5. We showed that the addition of
PCC, a PKC specific inhibitor, prior to incubation with
dbcAMP induced translocation of AQP5 to the plasma
membrane, indicating that PKC was not involved in the
dbcAMP-induced trafficking in the present MDCK cells (Fig.
3). Activation of PKC by PMA did not induce trafficking,
either (data not shown).
In HSG, a submandibular gland cell line, AQP5 expressed by
transfection is translocated to the plasma membrane depending
upon increase of cellular calcium ion [6], while it is trafficked to
the plasma membrane by PKA-dependent fashion in the
duodenal Brunner's gland [15]. Therefore, the cell type AQP5
is expressed may in part affect the protein kinase species which
become involved in the phosphorylation of AQP5. In MDCK
cells, but not the submandibular gland cells, PKA-anchoring
proteins (AKAPs) might be expressed to induce the cAMP-
dependent translocation, although the detail mechanism is still
unknown.
On the other hand, sodium nitroprusside, L-arginine, and
atrial natriuretic peptide as well as permeable cGMP analogs are
known to increase cGMP levels and induce AQP2 trafficking in
kidney collecting duct cells both in vivo and in vitro. Bouley et
al. [16] reported that PKG phosphorylates the carboxyl terminus
of AQP2 in vitro and that cGMP-stimulated membrane
accumulation of AQP2 does not occur in cells expressing the
S256A mutation of AQP2. In this report, to determine whether a
putative PKA/PKG target motif (256–259 (Arg–Lys–Lys–
Thr)) was involved in the phosphorylation and the translocation
of GFP–AQP5, we prepared GFP–AQP5–T259A and AQP5–
GFP–T259A expression constructs in which Thr-259 was
mutated to Ala to generate the non-phosphorylated state and
used these constructs to stably transfect MDCK cells.
Stimulation of the cells with dbcAMP caused the translocation
of GFP–AQP5–T259A to the plasma membrane, whereas H-89
inhibited such translocation, as has been demonstrated for wild-
type GFP–AQP5. GFP–AQP5–T259A having a mutation at a
putative PKA/PKG phosphorylation site did not show any
effect on the translocation by dbcAMP, suggesting that this
putative PKA/PKG target motif (256–259 (Arg–Lys–Lys–
Thr)) was not involved in the regulation of GFP–AQP5 in
MDCK cells.
Some AKAPs are abundant in the fraction of AQP2-
immunopurified vesicles prepared from IMCD cells. Inhibition
of forskolin-induced AQP2 translocation with a peptide that
prevents PKA–AKAP interaction demonstrated that, besides its
enzymatic activity, tethering of PKA to subcellular compart-
ment is essential for AQP2 translocation [17]. The use of the
present cells has, of course, a limitation and the experiment with
a salivary gland cell line or MLE12 cells would significantly
support the present finding.
Based on our observations, the GFP–AQP5 but not
AQP5–GFP chimera will be useful to study AQP5 trafficking
in vitro; exploring the protein that interacts with carboxyl-
terminal sequence of AQP5 is important to understand the
mechanism of AQP5 trafficking, and is need to be determined
in the future.
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